extensive-stage small cell lung cancer

Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche’s Tecentriq
Fierce Pharma
Tue, 10/15/24 - 11:03 am
Jazz Pharma
Zepzelca
extensive-stage small cell lung cancer
Roche
Tecentriq
ASCO: Is the PD-1 target behind Keytruda's small-cell miss? Merck exec says no
Fierce Pharma
Wed, 05/13/20 - 10:38 pm
ASCO 2020
Merck
Keytruda
extensive-stage small cell lung cancer
Roche gets Chinese approval for Tecentriq plus chemotherapy to treat ES-SCLC
Pharmaceutical Business Review
Fri, 02/14/20 - 10:36 am
Roche
China
NMPA
Tecentriq
extensive-stage small cell lung cancer
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
BioSpace
Thu, 06/27/19 - 06:38 pm
AstraZeneca
clinical trials
Imfinzi
extensive-stage small cell lung cancer
Calquence
CLL
AZ’s Imfinzi on target in small cell lung cancer, sets up Roche rivalry
Pharmaforum
Thu, 06/27/19 - 09:34 am
AstraZeneca
Imfinzi
extensive-stage small cell lung cancer
Roche
Tecentriq
Roche’s Tecentriq gains new US lung cancer indication
Pharmaforum
Tue, 03/19/19 - 11:41 am
Roche
Genentech
Tecentriq
FDA
extensive-stage small cell lung cancer
Tecentriq could be first front-line SCLC therapy approved in two decades
BioCentury
Wed, 12/5/18 - 07:46 pm
FDA
Tecentriq
Genentech
extensive-stage small cell lung cancer
BMS' second small-cell trial flop endangers Opdivo lung cancer approval: analyst
Fierce Pharma
Tue, 11/27/18 - 11:39 pm
Bristol-Myers Squibb
Opdivo
Yervoy
extensive-stage small cell lung cancer
Bristol-Myers Drops After Lung-Cancer Drug Study Fails
TheStreet.com
Tue, 11/27/18 - 12:15 pm
Bristol-Myers Squibb
Opdivo
Yeroy
extensive-stage small cell lung cancer